E
Aethlon Medical, Inc.
AEMD
$1.39
$0.0251.83%
E
Sell
9/18/2023Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 9/18/2023 due to a decline in the volatility index.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 9/18/2023 due to a decline in the volatility index.
D
Sell
8/29/2023Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 8/29/2023 due to an increase in the total return index and volatility index.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 8/29/2023 due to an increase in the total return index and volatility index.
E
Sell
8/14/2023Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 8/14/2023 due to a decline in the growth index, solvency index and volatility index. EBIT declined 37.54% from -$2.48M to -$3.41M, the quick ratio declined from 9.66 to 7.08, and earnings per share declined from -$0.1114 to -$0.14.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 8/14/2023 due to a decline in the growth index, solvency index and volatility index. EBIT declined 37.54% from -$2.48M to -$3.41M, the quick ratio declined from 9.66 to 7.08, and earnings per share declined from -$0.1114 to -$0.14.
D
Sell
8/2/2023Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 8/2/2023 due to an increase in the total return index, volatility index and growth index. EBIT increased 13.05% from -$2.85M to -$2.48M, and earnings per share increased from -$0.1242 to -$0.1114.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 8/2/2023 due to an increase in the total return index, volatility index and growth index. EBIT increased 13.05% from -$2.85M to -$2.48M, and earnings per share increased from -$0.1242 to -$0.1114.
E
Sell
3/14/2023Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/14/2023Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 2/14/2023 due to an increase in the growth index and total return index. Earnings per share increased from -$0.1835 to -$0.1242, operating cash flow increased 32.22% from -$2.88M to -$1.95M, and EBIT increased 22.25% from -$3.67M to -$2.85M.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 2/14/2023 due to an increase in the growth index and total return index. Earnings per share increased from -$0.1835 to -$0.1242, operating cash flow increased 32.22% from -$2.88M to -$1.95M, and EBIT increased 22.25% from -$3.67M to -$2.85M.
E
Sell
2/8/2023Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 2/8/2023 due to a decline in the growth index, total return index and volatility index. EBIT declined 26.12% from -$2.91M to -$3.67M, and operating cash flow declined 5.48% from -$2.73M to -$2.88M.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 2/8/2023 due to a decline in the growth index, total return index and volatility index. EBIT declined 26.12% from -$2.91M to -$3.67M, and operating cash flow declined 5.48% from -$2.73M to -$2.88M.
D
Sell
11/17/2022Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 11/17/2022 due to a major decline in the solvency index, volatility index and total return index. The quick ratio declined from 9.43 to 9.14.
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 11/17/2022 due to a major decline in the solvency index, volatility index and total return index. The quick ratio declined from 9.43 to 9.14.
D
Sell
7/28/2022Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 7/28/2022 due to an increase in the total return index, volatility index and valuation index.
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 7/28/2022 due to an increase in the total return index, volatility index and valuation index.
D
Sell
6/24/2022Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 6/24/2022 due to a decline in the volatility index.
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 6/24/2022 due to a decline in the volatility index.
D
Sell
6/9/2022Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 6/9/2022 due to an increase in the volatility index.
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 6/9/2022 due to an increase in the volatility index.
D
Sell
5/31/2022Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 5/31/2022 due to an increase in the total return index and volatility index.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 5/31/2022 due to an increase in the total return index and volatility index.
E
Sell
5/13/2022Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 5/13/2022 due to a decline in the total return index and volatility index.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
2/16/2022Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 2/16/2022 due to a significant decline in the total return index, growth index and volatility index. Total revenue declined 87.05% from $132 to $17.1, operating cash flow declined 44.73% from -$1.88M to -$2.72M, and EBIT declined 25.84% from -$2.01M to -$2.53M.
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 2/16/2022 due to a significant decline in the total return index, growth index and volatility index. Total revenue declined 87.05% from $132 to $17.1, operating cash flow declined 44.73% from -$1.88M to -$2.72M, and EBIT declined 25.84% from -$2.01M to -$2.53M.
D
Sell
11/11/2021Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 11/11/2021 due to an increase in the growth index. Earnings per share increased from -$0.1635 to -$0.1305, operating cash flow increased 9.35% from -$2.07M to -$1.88M, and EBIT increased 4.27% from -$2.1M to -$2.01M.
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 11/11/2021 due to an increase in the growth index. Earnings per share increased from -$0.1635 to -$0.1305, operating cash flow increased 9.35% from -$2.07M to -$1.88M, and EBIT increased 4.27% from -$2.1M to -$2.01M.
D
Sell
11/8/2021Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
2/12/2021Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 2/12/2021 due to an increase in the volatility index and total return index.
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 2/12/2021 due to an increase in the volatility index and total return index.
D
Sell
1/28/2021Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 1/28/2021 due to a decline in the volatility index.
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 1/28/2021 due to a decline in the volatility index.
D
Sell
1/7/2021Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 1/7/2021 due to an increase in the volatility index, total return index and growth index.
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 1/7/2021 due to an increase in the volatility index, total return index and growth index.
D
Sell
10/30/2020Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 10/30/2020 due to a decline in the growth index, volatility index and solvency index. EBIT declined 25.6% from -$1.41M to -$1.77M, the quick ratio declined from 13.02 to 9.79, and operating cash flow declined 11.33% from -$1.1M to -$1.23M.
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 10/30/2020 due to a decline in the growth index, volatility index and solvency index. EBIT declined 25.6% from -$1.41M to -$1.77M, the quick ratio declined from 13.02 to 9.79, and operating cash flow declined 11.33% from -$1.1M to -$1.23M.
D
Sell
9/28/2020Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 9/28/2020 due to an increase in the volatility index and total return index.
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 9/28/2020 due to an increase in the volatility index and total return index.
D
Sell
9/11/2020Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 9/11/2020 due to a decline in the volatility index.
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 9/11/2020 due to a decline in the volatility index.
D
Sell
8/14/2020Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 8/14/2020 due to an increase in the volatility index, growth index and solvency index. The quick ratio increased from 9.19 to 13.02, operating cash flow increased 31.99% from -$1.62M to -$1.1M, and earnings per share increased from -$0.2176 to -$0.15.
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 8/14/2020 due to an increase in the volatility index, growth index and solvency index. The quick ratio increased from 9.19 to 13.02, operating cash flow increased 31.99% from -$1.62M to -$1.1M, and earnings per share increased from -$0.2176 to -$0.15.
D
Sell
8/4/2020Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 8/4/2020 due to a decline in the volatility index.
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 8/4/2020 due to a decline in the volatility index.
D
Sell
7/17/2020Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 7/17/2020 due to an increase in the volatility index, growth index and total return index.
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 7/17/2020 due to an increase in the volatility index, growth index and total return index.
D
Sell
6/29/2020Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 6/29/2020 due to a decline in the volatility index, growth index and valuation index. EBIT declined 103.7% from -$876.4 to -$1.79M, total revenue declined 50.01% from $413.5 to $206.7, and operating cash flow declined 28.97% from -$1.26M to -$1.62M.
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 6/29/2020 due to a decline in the volatility index, growth index and valuation index. EBIT declined 103.7% from -$876.4 to -$1.79M, total revenue declined 50.01% from $413.5 to $206.7, and operating cash flow declined 28.97% from -$1.26M to -$1.62M.
D
Sell
6/18/2020Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 6/18/2020 due to an increase in the volatility index.
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 6/18/2020 due to an increase in the volatility index.
D
Sell
4/20/2020Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 4/20/2020 due to an increase in the volatility index and total return index.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 4/20/2020 due to an increase in the volatility index and total return index.
E
Sell
4/3/2020Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 4/3/2020 due to a decline in the volatility index.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 4/3/2020 due to a decline in the volatility index.
D
Sell
3/16/2020Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 3/16/2020 due to an increase in the volatility index, total return index and valuation index.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 3/16/2020 due to an increase in the volatility index, total return index and valuation index.
E
Sell
2/28/2020Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 2/28/2020 due to a decline in the volatility index and total return index.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 2/28/2020 due to a decline in the volatility index and total return index.
D
Sell
2/11/2020Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 2/11/2020 due to a noticeable increase in the growth index, solvency index and valuation index. The quick ratio increased from 0.67 to 5.26, debt to equity declined from 0.64 to 0.02, and earnings per share increased from -$1.2942 to -$0.2838.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 2/11/2020 due to a noticeable increase in the growth index, solvency index and valuation index. The quick ratio increased from 0.67 to 5.26, debt to equity declined from 0.64 to 0.02, and earnings per share increased from -$1.2942 to -$0.2838.
E
Sell
11/15/2019Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 11/15/2019 due to a noticeable decline in the efficiency index, valuation index and solvency index. Total capital declined 90.18% from $2.12M to $208.2, and the quick ratio declined from 1.39 to 0.67.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 11/15/2019 due to a noticeable decline in the efficiency index, valuation index and solvency index. Total capital declined 90.18% from $2.12M to $208.2, and the quick ratio declined from 1.39 to 0.67.
D
Sell
10/29/2019Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 10/29/2019 due to an increase in the valuation index, total return index and volatility index.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 10/29/2019 due to an increase in the valuation index, total return index and volatility index.
E
Sell
10/14/2019Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 10/14/2019 due to a large decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.4 to 0.86, and the quick ratio declined from 2.1 to 1.39.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 10/14/2019 due to a large decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.4 to 0.86, and the quick ratio declined from 2.1 to 1.39.
D
Sell
2/15/2019Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 2/15/2019 due to a noticeable increase in the total return index, volatility index and efficiency index.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 2/15/2019 due to a noticeable increase in the total return index, volatility index and efficiency index.
E
Sell
11/7/2018Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D on 11/7/2018 due to a decline in the efficiency index, growth index and valuation index. Earnings per share declined from -$0.0646 to -$0.08, EBIT declined 22.76% from -$1.1M to -$1.35M, and net income declined 21.56% from -$1.15M to -$1.39M.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D on 11/7/2018 due to a decline in the efficiency index, growth index and valuation index. Earnings per share declined from -$0.0646 to -$0.08, EBIT declined 22.76% from -$1.1M to -$1.35M, and net income declined 21.56% from -$1.15M to -$1.39M.
D
Sell
6/8/2018Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 6/8/2018 due to an increase in the efficiency index, valuation index and solvency index. Total capital increased 26.96% from $5.41M to $6.87M, and debt to equity declined from 0.17 to 0.14.
Aethlon Medical, Inc. (AEMD) was upgraded to D from D- on 6/8/2018 due to an increase in the efficiency index, valuation index and solvency index. Total capital increased 26.96% from $5.41M to $6.87M, and debt to equity declined from 0.17 to 0.14.
D
Sell
3/29/2018Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 3/29/2018 due to an increase in the total return index, volatility index and valuation index.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 3/29/2018 due to an increase in the total return index, volatility index and valuation index.
E
Sell
2/2/2018Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 2/2/2018 due to a decline in the efficiency index, valuation index and total return index.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 2/2/2018 due to a decline in the efficiency index, valuation index and total return index.
D
Sell
8/11/2017Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 8/11/2017 due to a noticeable increase in the growth index, efficiency index and valuation index. EBIT increased 22.87% from -$1.5M to -$1.16M, and earnings per share increased from -$0.2175 to -$0.21.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 8/11/2017 due to a noticeable increase in the growth index, efficiency index and valuation index. EBIT increased 22.87% from -$1.5M to -$1.16M, and earnings per share increased from -$0.2175 to -$0.21.
E
Sell
6/29/2017Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 6/29/2017 due to a noticeable decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.1521 to -$0.2204, EBIT declined 21.76% from -$1.24M to -$1.5M, and operating cash flow declined 21.04% from -$788.2 to -$954.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 6/29/2017 due to a noticeable decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.1521 to -$0.2204, EBIT declined 21.76% from -$1.24M to -$1.5M, and operating cash flow declined 21.04% from -$788.2 to -$954.
D
Sell
2/16/2017Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 2/16/2017 due to a noticeable decline in the solvency index, efficiency index and valuation index. Debt to equity increased from -8.96 to 5.56, and total capital declined 12.04% from $472.4 to $415.5.
Aethlon Medical, Inc. (AEMD) was downgraded to D- from D on 2/16/2017 due to a noticeable decline in the solvency index, efficiency index and valuation index. Debt to equity increased from -8.96 to 5.56, and total capital declined 12.04% from $472.4 to $415.5.
D
Sell
11/11/2016Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D from E+ on 11/11/2016 due to a noticeable increase in the valuation index, efficiency index and growth index. Total revenue increased 8,321.74% from $4.6 to $387.4.
Aethlon Medical, Inc. (AEMD) was upgraded to D from E+ on 11/11/2016 due to a noticeable increase in the valuation index, efficiency index and growth index. Total revenue increased 8,321.74% from $4.6 to $387.4.
E
Sell
8/12/2016Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 8/12/2016 due to a noticeable decline in the efficiency index, solvency index and growth index. Debt to equity increased from 0.34 to 1.42, total revenue declined 97.75% from $204.7 to $4.6, and net income declined 70.65% from -$1.25M to -$2.13M.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D- on 8/12/2016 due to a noticeable decline in the efficiency index, solvency index and growth index. Debt to equity increased from 0.34 to 1.42, total revenue declined 97.75% from $204.7 to $4.6, and net income declined 70.65% from -$1.25M to -$2.13M.
D
Sell
7/15/2016Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 7/15/2016 due to a significant increase in the solvency index, efficiency index and growth index.
Aethlon Medical, Inc. (AEMD) was upgraded to D- from E+ on 7/15/2016 due to a significant increase in the solvency index, efficiency index and growth index.
E
Sell
6/30/2016Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D on 6/30/2016 due to a significant decline in the solvency index, growth index and total return index.
Aethlon Medical, Inc. (AEMD) was downgraded to E+ from D on 6/30/2016 due to a significant decline in the solvency index, growth index and total return index.
D
Sell
3/11/2016Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index.
Aethlon Medical, Inc. (AEMD) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index.
D
Sell
2/5/2016Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D+ from D on 2/5/2016 due to a substantial increase in the volatility index and growth index. Total revenue increased 59.77% from $188.4 to $301.
Aethlon Medical, Inc. (AEMD) was upgraded to D+ from D on 2/5/2016 due to a substantial increase in the volatility index and growth index. Total revenue increased 59.77% from $188.4 to $301.
D
Sell
10/26/2015Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D from D+ on 10/26/2015 due to a decline in the total return index.
Aethlon Medical, Inc. (AEMD) was downgraded to D from D+ on 10/26/2015 due to a decline in the total return index.
D
Sell
9/9/2015Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D+ from D on 9/9/2015 due to an increase in the total return index, growth index and valuation index.
Aethlon Medical, Inc. (AEMD) was upgraded to D+ from D on 9/9/2015 due to an increase in the total return index, growth index and valuation index.
D
Sell
8/14/2015Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D from D+ on 8/14/2015 due to a decline in the growth index and volatility index. Operating cash flow declined 57.95% from -$1.9M to -$798, EBIT declined 3.77% from -$1.13M to -$1.09M, and total revenue declined 3.07% from $198.6 to $192.5.
Aethlon Medical, Inc. (AEMD) was downgraded to D from D+ on 8/14/2015 due to a decline in the growth index and volatility index. Operating cash flow declined 57.95% from -$1.9M to -$798, EBIT declined 3.77% from -$1.13M to -$1.09M, and total revenue declined 3.07% from $198.6 to $192.5.
D
Sell
6/26/2015Upgraded
Aethlon Medical, Inc. (AEMD) was upgraded to D+ from D on 6/26/2015 due to a noticeable increase in the growth index and solvency index. Total revenue increased 494.61% from $33.4 to $198.6, operating cash flow increased 7.98% from -$1.76M to -$1.9M, and the quick ratio increased from 1.75 to 1.83.
Aethlon Medical, Inc. (AEMD) was upgraded to D+ from D on 6/26/2015 due to a noticeable increase in the growth index and solvency index. Total revenue increased 494.61% from $33.4 to $198.6, operating cash flow increased 7.98% from -$1.76M to -$1.9M, and the quick ratio increased from 1.75 to 1.83.
D
Sell
6/8/2015Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D from D+ on 6/8/2015 due to a large decline in the volatility index and total return index.
Aethlon Medical, Inc. (AEMD) was downgraded to D from D+ on 6/8/2015 due to a large decline in the volatility index and total return index.
D
Sell
4/28/2015Upgraded
Aethlon Medical, Inc. (AEMDD) was upgraded to D+ from D on 4/28/2015 due to an increase in the volatility index and valuation index.
Aethlon Medical, Inc. (AEMDD) was upgraded to D+ from D on 4/28/2015 due to an increase in the volatility index and valuation index.
D
Sell
4/13/2015Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D from D+ on 4/13/2015 due to a large decline in the total return index and valuation index.
Aethlon Medical, Inc. (AEMD) was downgraded to D from D+ on 4/13/2015 due to a large decline in the total return index and valuation index.
D
Sell
2/11/2015Downgrade
Aethlon Medical, Inc. (AEMD) was downgraded to D+ from C on 2/11/2015 due to a significant decline in the efficiency index and growth index. Total capital declined 247.15% from -$1.63M to $2.39M, and total revenue declined 93.03% from $479.1 to $33.4.
Aethlon Medical, Inc. (AEMD) was downgraded to D+ from C on 2/11/2015 due to a significant decline in the efficiency index and growth index. Total capital declined 247.15% from -$1.63M to $2.39M, and total revenue declined 93.03% from $479.1 to $33.4.
NASDAQ
05/03/2024 3:35PM Eastern
Quotes delayed
